Patents by Inventor Volker Ganser

Volker Ganser has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 4861770
    Abstract: The use of benzothiazepine derivatives for the protection of lymphocytes in humans and higher mammals, especially in the treatment of acquired immune deficiency syndrome.
    Type: Grant
    Filed: February 1, 1988
    Date of Patent: August 29, 1989
    Assignee: Goedecke Aktiengesellschaft
    Inventors: Ute Weiershausen, Volker Ganser, Gerhard Satzinger
  • Patent number: 4598076
    Abstract: The present invention provides compounds of the general formula I ##STR1## wherein R.sup.1 and R.sup.2, which are the same or different, are unsubstituted or substituted aromatic rings, Alk is a straight-chained or branched lower hydrocarbon chain and Z is a hydrogen atom, with the proviso that when Alk is a straight-chained hydrocarbon chain, Z can also be a lower alkylamino radical of the general formula II ##STR2## in which R.sup.3 and R.sup.4 are the same or different and are hydrogen atoms or straight-chained or branched lower alkyl radicals or R.sup.3 and R.sup.4, together with the nitrogen atom to which they are attached, can also form a ring optionally containing further hetero atoms; and the pharmacologically acceptable salts thereof.The present invention also provides an inventive process for preparing these compounds, as well as pharmaceutical compositions containing them. The compounds I may be used in the therapy of inflammations and they are free of gastrointestinal side effects.
    Type: Grant
    Filed: January 14, 1985
    Date of Patent: July 1, 1986
    Assignee: Warner-Lambert Company
    Inventors: Hubert Barth, Edgar Fritschi, Volker Ganser, Johannes Hartenstein, Manfred Herrmann, Gerhard Satzinger
  • Patent number: 4517185
    Abstract: The present invention provides compounds of the general formula I ##STR1## wherein R.sup.1 and R.sup.2, which are the same or different, are unsubstituted or substituted aromatic rings, Alk is a straight-chained or branched lower hydrocarbon chain and Z is a hydrogen atom, with the proviso that when Alk is a straight-chained hydrocarbon chain, Z can also be a lower alkylamino radical of the general formula II ##STR2## in which R.sup.3 and R.sup.4 are the same or different and are hydrogen atoms or straight-chained or branched lower alkyl radicals or R.sup.3 and R.sup.4, together with the nitrogen atom to which they are attached, can also form a ring optionally containing further hetero atoms; and the pharmacologically acceptable salts thereof.The present invention also provides an inventive process for preparing these compounds, as well as pharmaceutical compositions containing them. The compounds I may be used in the therapy of inflammations and they are free of gastrointestinal side effects.
    Type: Grant
    Filed: March 25, 1983
    Date of Patent: May 14, 1985
    Assignee: Warner-Lambert Company
    Inventors: Hubert Barth, Edgar Fritschi, Volker Ganser, Johannes Hartenstein, Manfred Herrmann, Gerhard Satzinger
  • Patent number: 4499089
    Abstract: 2-Alkylthio-1-aminoalkyl-2-pyrroline-3-carbonitriles and pharmaceutically acceptable acid addition salts, processes for their preparation and formulation into pharmaceutical compositions as well as their activity as thrombocyte aggregation-inhibitors are described. The compounds are thus useful for the prophylaxis and therapy of thrombotic states.
    Type: Grant
    Filed: May 10, 1984
    Date of Patent: February 12, 1985
    Assignee: Warner-Lambert Company
    Inventors: Hubert Barth, Johannes Hartenstein, Gerhard Satzinger, Edgar Fritschi, Volker Ganser, Horst-Dietmar Tauschel, Gunter Wolf
  • Patent number: 4415495
    Abstract: The present invention provides 5,6;8,9-tetrahydro-7H-dibenz(d,f)azonine derivatives of the formula: ##STR1## wherein R.sup.1 and R.sup.2, which are the same or different, are hydrogen or halogen atoms or lower alkyl or alkoxy radicals, R.sup.3 is a hydrogen atom or a lower alkyl radical, R.sup.4 is a hydrogen atom or a lower alkyl or alkanoyl radical and n is 1 or 2; and the pharmaceutically acceptable salts thereof formed with inorganic and organic acids; but excluding 6-benzyl-2,12-dimethoxy-1-hydroxy-7-methyl-5,6;8,9-tetrahydro-7H-dibenz(d, f)azonine in which case R.sup.1, R.sup.2 and R.sup.4 are hydrogen, n is 1 and R.sup.3 is methyl. The lower alkyl, alkanoyl and alkoxy radicals are straight chained or branched radicals containing 1 to 5 carbon atoms.The present invention also provides a process for the preparation of these compounds, as well as pharmaceutical compositions containing them.
    Type: Grant
    Filed: February 24, 1981
    Date of Patent: November 15, 1983
    Assignee: Godecke Aktiengesellschaft
    Inventors: Gerhard Satzinger, Manfred Herrmann, Edgar Fritschi, Heinrich Bahrmann, Volker Ganser, Bernd Wagner, Wolfgang Steinbrecher
  • Patent number: 4294834
    Abstract: Novel azocine derivatives and a method for their preparation are disclosed. The compounds display analgesic effects in mammals.
    Type: Grant
    Filed: November 13, 1979
    Date of Patent: October 13, 1981
    Assignee: Godecke Aktiengesellschaft
    Inventors: Johannes Hartenstein, Gerhard Satzinger, Heinrich Bahrmann, Volker Ganser